Burning Rock Biotech Ltd (BNR) — Cash Flow Reinvestment Rate
Latest as of March 2026:
0.23x
Burning Rock Biotech Ltd (BNR) has a Cash Flow Reinvestment Rate of 0.23x as of March 2026, reinvesting $5.25 Million (capex $5.25 Million ) from operating cash flow of $23.04 Million. Explore cash efficiency ratio of Burning Rock Biotech Ltd to assess how effectively this company generates cash.
Reinvestment Rate
0.23x
(Capex + Investments) / Operating CF
Total Reinvested
$5.25 Million
Capex + Investments
Operating Cash Flow
$23.04 Million
USD
Capital Expenditures
$5.25 Million
USD
Annual Cash Flow Reinvestment Rate for Burning Rock Biotech Ltd (None–None)
Year-by-year capital reinvestment analysis for Burning Rock Biotech Ltd. For live market cap and broader valuation context, see BNR market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow